Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PER2 | O15055 | 1/20 | 0.33 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.33 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10315679 | 0.92 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL10315682 | 0.92 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL10315683 | 0.91 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL15894186 | 0.89 | KDM4E (0.44) | L3MBTL1KDM4EATMRXFP1MAPT | |
| SCHEMBL17539872 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL17539875 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL10315686 | 0.88 | TSPO (0.39) | L3MBTL1KDM4EATMRXFP1OPRD1 | |
| SCHEMBL17539877 | 0.87 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMOPRD1MAPT | |
| SCHEMBL10309964 | 0.86 | KDM4E (0.43) | L3MBTL1KDM4EATMRXFP1MAPT | |
| SCHEMBL13803403 | 0.86 | KDM4E (0.43) | L3MBTL1KDM4EATMRXFP1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9450192-B2 | Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof | E-RAY OPTOELECTRONICS TECHNOLOGY (TW) | 2016-09-20 | — | — | US | disclosed |
| US-9450192-B2 | Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof | E-RAY OPTOELECTRONICS TECHNOLOGY (TW) | 2016-09-20 | — | — | US | disclosed |
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | AHR, ARNT, NAT1 | L3MBTL1 2732/4885KDM4E 2441/4885ATM 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.